Neonatal lesions in the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood

Psychopharmacology

Volumn 132, Issue 3, 1997, Pages 303-310

  Sams Dodd, Frank ^a   Lipska, Barbara K ^b   Weinberger, Daniel R ^b  

^a H LUNDBECK A S   (Denmark)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Hippocampus; Hyperactivity; Negative symptoms; Neonate; Positive symptoms; Rat; Schizophrenia; Social behaviour

Indexed keywords

CLOZAPINE; IBOTENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HISTOLOGY; HYPERACTIVITY; LOCOMOTION; MALE; NEGATIVE SYNDROME; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RAT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL ISOLATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; FEMALE; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SOCIAL BEHAVIOR;

EID: 0030839774     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050349     Document Type: Article

References (32)

1. Auerbach JG, Hans S, Marcus J (1993) Neurobehavioral functioning and social behavior of children at risk for schizophrenia. Israel J Psychiatr Rel Sci 30:40-49
2. Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701-707
3. Black MD, Hitchcock JM, Sorensen SM (1996) Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Soc Neurosci Abstr 22:16-76
4. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT (1994) Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 151:20-26
5. Davies BM, Beech HR (1960) The effects of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers. J Men Sci 106: 912-914
6. Done DJ, Crow TJ, Johnstone EC, Sacker A (1994) Childhood antecedents of schizophrenia and affective illness:social adjustment at ages 7 and 11. BMJ 309:699-703
7. Eaton WW, Tien AY, Poeschla BD (1995) Epidemiology of schizophrenia. In: Den Boer JA, Westenberg HGM, van Praag HM (eds) Advances in the neurobiology of schizophrenia. Wiley, New York, pp 27-57
8. Ellinwood EH (1967) Amphetamine psychosis: I. Description of the individuals and process. J Nerv Ment Dis 144: 273-283
9. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2:219-238
10. 3 receptors in limbic subregions after bilateral lesion of rat hippocampus. J Neurosci 16:2020-2026
11. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schulz SC, Weinberger DR (1993) The effects of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 162:43-48
12. Greifenstein FE, Yoshitake J, DeValut M, Gajewski JE (1958) A study of 1-aryl cyclo hexyl amine for anesthesia. Anesth Analg 37:283-294
13. Huitema BE (1980) The analysis of covariants and alternatives. Wiley, New York
14. Jones P, Rodgers B, Murray R, Marmot M (1994) Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344:1398-1402
15. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 49:789-796
16. Kay SR, Opler LA, Fiszbein A (1987) Positive and negative syndrome scale (PANSS) Rating manual. Social and Behavioural Science Documents, San Rafael, Calif.
17. Lipska BK, Weinberger DR (1994) Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10: 199-205
18. Lipska BK, Weinberger DR (1995) Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in the rat. Proc Natl Acad Sci, USA 92:8906-8910
19. Lipska BK, Weinberger DR (1996) Hippocampal damage in the neonatal rat as a model of some aspects of schizophrenia. In: Kato N (ed) The hippocampus: functions and clinical relevance. Elsevier, Amsterdam, pp 465-475
20. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75
21. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35-43
22. Litman RE, Hommer DW, Radant A, Clem T, Pickar D (1994) Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia. Schizophr Res 12:107-120
23. McLaren S, Cookson JC, Silverstone T (1992) Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. Int Clin Psychopharmacol 7:67-72
24. Meltzer HY, Alphs LD, Bastani B, Ramirez LF, Kwon K (1991) Clinical efficacy of clozapine in the treatment of schizophrenia. Pharmacopsychiatry 24:44-45
25. Neuechterlein KH (1986) Childhood precursors of adult schizophrenia. J Child Psychol 27:133-144
26. Sams-Dodd F (1995a) Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65
27. Sams-Dodd F (1995b) Automation of the social interaction test by a video tracking system: behavioural effects of repeated phencyclidine treatment. J Neurosci Meth 59:157-168
28. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in the rat: a possible animal model of schizophrenia. Behav Pharmacol 7:3-23
29. Siegel RK (1978) Phencyclidine and ketamine intoxication a study of 4 populations of recreational users. In: Peterson RC, Stillman RC (eds) National Institute of Drug Abuse Research Monograph #21. NIH Press, Washington DC, pp 119-147
30. Snyder SH (1973) Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am J Psychiatry 130:61-67
31. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165-174
32. Weinberger DR, Lipska BK (1995) Cortical maldevelopment, antipsychotic drugs, and schizophrenia: in search of common ground. Schizophr Res 16:87-110